Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 600
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00323206 | Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma | ||
| NCT05579847 | Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy | ||
| NCT02513563 | AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer | ||
| NCT03904199 | Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia | ||
| NCT04388839 | Evolutionary Therapy for Rhabdomyosarcoma | ||
| NCT01681875 | Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes | ||
| NCT05732961 | Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms | ||
| NCT02440425 | Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer | ||
| NCT02115542 | Single Agent Regorafenib in Refractory Advanced Biliary Cancers | ||
| NCT06295159 | Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma | ||
| NCT00637689 | Improving Outcomes Assessment in Chronic GVHD | ||
| NCT00400569 | Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma | ||
| NCT03077113 | Pilot Study of Regional Lung Ventilation | ||
| NCT01672944 | Evaluating Biobanking Educational Tools | ||
| NCT06923033 | Aim 1: App for Reducing Cravings to Smoke | ||
| NCT05024552 | Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML | ||
| NCT03043599 | Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer | ||
| NCT01434069 | Phase I Trial of Combination of FOLFIRI and SOM 230 | ||
| NCT00005641 | Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation | ||
| NCT04588545 | Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease | ||
| NCT00101101 | Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma | ||
| NCT05649969 | STRONG Program for Cancer Patients | ||
| NCT02403193 | Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) | ||
| NCT00006047 | Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide | ||
| NCT01435122 | A Study of Axitinib in Advanced Carcinoid Tumors | ||
| NCT05763563 | Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy | ||
| NCT05316116 | Siltuximab in Large Granular Lymphocytic Leukemia (LGLL) | ||
| NCT05177211 | Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL) | ||
| NCT05645471 | Together After Cancer | ||
| NCT03611738 | Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC | ||
| NCT05704933 | Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases | ||
| NCT01302626 | Radiomics: a Study of Outcome in Lung Cancer | ||
| NCT03663166 | Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT06961357 | Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma | ||
| NCT00798629 | Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured | ||
| NCT01008527 | Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100 | ||
| NCT05524935 | Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma | ||
| NCT01657591 | Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma | ||
| NCT06305676 | Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC) | ||
| NCT00215943 | Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) | ||
| NCT01823991 | COGNUTRIN in Breast Cancer Survivors | ||
| NCT06409390 | Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer | ||
| NCT00444015 | Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC) | ||
| NCT03177291 | Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC | ||
| NCT00215956 | A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma | ||
| NCT06909357 | Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients | ||
| NCT04596579 | SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida | ||
| NCT00612677 | Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem | ||
| NCT07249775 | A First-in-Human Study of FID-022 in Solid Tumor Patients | ||
| NCT04242173 | Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC |
